Labshake search
Citations for Agilent :
1 - 50 of 466 citations for VTI1A Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: HLA-restriction of antigen recognition was tested in anti-IFN-γ ELISpot using autologous DCs loaded with the relevant peptide or without peptide (negative control) and blocking antibodies against HLA class I and II (both Dako). DCs were incubated with peptides overnight and the next day anti-HLA mABs were added to ELISpot plates for 1 hour prior to the addition of expanded cells at a ratio of 1 DC to 50 expanded cells ...
-
bioRxiv - Cancer Biology 2022Quote: ... Blocking was with serum-free protein blocking solution (Agilent) for 1 h ...
-
bioRxiv - Cancer Biology 2021Quote: ... After blocking with serum free protein blocking solution (Dako), slides were incubated for primary antibodies for 1h at RT ...
-
bioRxiv - Neuroscience 2021Quote: ... followed by blocking using DAKO blocking buffer (DAKO, Hamburg, Germany) for 60 minutes ...
-
bioRxiv - Immunology 2024Quote: ... After blocking (Agilent), the specimens were incubated with the indicated primary antibodies under specified conditions (Supplemental Table 2) ...
-
bioRxiv - Cell Biology 2021Quote: ... overnight at 4°C after blocking with blocking solution (S3022, Dako) for 30 min ...
-
bioRxiv - Immunology 2022Quote: ... After the blocking of endogenous peroxidases using Peroxidase-Blocking Solution (Dako), the sections were incubated overnight at 4°C with anti-ACE2 (1:100) ...
-
bioRxiv - Cell Biology 2020Quote: ... in blocking buffer (Dako), samples were incubated in primary antibodies overnight at 4°C ...
-
bioRxiv - Molecular Biology 2023Quote: ... After blocking with a non-specific staining blocking reagent (X0909, Dako, Carpinteria, CA), the slides were incubated with primary antibodies (shown in Suppl ...
-
bioRxiv - Molecular Biology 2021Quote: ... After blocking for 1 hour in serum-free protein blocking buffer (DAKO, catalog X0909), sections were incubated overnight at 4°C with anti–phospho-hsp25 (1:200 ...
-
bioRxiv - Bioengineering 2024Quote: ... peroxidase blocking solution and serum-free protein blocking solution were purchased from Dako (DNK). The O.C.T ...
-
bioRxiv - Cancer Biology 2019Quote: ... Protein Blocking reagent (Dako, X0909) and Bloxall blocking solution (Vector ...
-
bioRxiv - Pathology 2021Quote: ... Blocking buffer (Dako, Cat# S2003) was then applied for 10 minutes at room temperature ...
-
bioRxiv - Microbiology 2023Quote: ... After endogenous peroxidase blocking (Agilent Technologies ...
-
bioRxiv - Bioengineering 2023Quote: ... After blocking in DAKO (Agilent) for 1h ...
-
bioRxiv - Cancer Biology 2023Quote: ... Protein Blocking reagent (Dako, X0909) and Bloxall blocking solution (Vector ...
-
bioRxiv - Neuroscience 2020Quote: ... we used the endogenous biotin blocking procedure (Avidin/Biotin Blocking Kit, Dako, code No. X0590) according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... 100μL of Blocking Solution (Dako, USA) was added for 10 minutes at room temperature ...
-
bioRxiv - Cancer Biology 2021Quote: ... a peroxidase-blocking agent (DAKO S2023) was added for 8 minutes ...
-
bioRxiv - Cancer Biology 2019Quote: ... biotin and peroxidase blocking reagents (Dako) prior to primary antibody incubation and then with Bio-Rad Amplification Reagent (Bio-Rad ...
-
bioRxiv - Immunology 2020Quote: ... REAL peroxidase Blocking agent (Dako, Agilent) and casein solution (Vector labs ...
-
bioRxiv - Immunology 2020Quote: ... REAL peroxidase Blocking agent (Dako, Agilent) and casein solution (Vector labs ...
-
bioRxiv - Cell Biology 2020Quote: ... biotin and peroxydase blocking reagents (Dako) before saturation with TBS containing 0.1% Tween-20 and 5% BSA (TBST-BSA) ...
-
bioRxiv - Cell Biology 2023Quote: ... After incubation with blocking buffer (Agilent), primary antibodies prepared in antibody diluent (Agilent ...
-
bioRxiv - Developmental Biology 2023Quote: ... Peroxidase Blocking Solution (DAKO, Cat# S2023) was applied for 10 minutes and non-specific binding was prevented with AffiniPure Fab Fragment Goat Anti-Mouse IgG for 1 hour ...
-
bioRxiv - Cancer Biology 2023Quote: ... treated with peroxidase blocking reagent (Dako) and incubated with primary antibodies at the concentration indicated in Table S7 ...
-
bioRxiv - Cancer Biology 2021Quote: ... blocked in serum-free blocking reagent (DAKO) and incubated with primary antibodies for 1hr at room temperature ...
-
bioRxiv - Immunology 2021Quote: ... followed by avidin and biotin blocking (Dako) before staining with the second tetramer ...
-
bioRxiv - Cancer Biology 2023Quote: ... The sections underwent peroxidase blocking (S2023, Agilent) for 5 minutes and were then rinsed with flex buffer before applying BrdU antibody to the sections at a previously optimised dilution (1/250 ...
-
bioRxiv - Cancer Biology 2024Quote: ... subjected to endogenous peroxidase blocking (#S2023, Agilent) for 5 min ...
-
bioRxiv - Cell Biology 2024Quote: ... Step 3 was endogenous peroxidase blocking (Dako REAL Peroxidase-blocking reagent ...
-
bioRxiv - Immunology 2024Quote: ... serum-free-blocking diluent (Dako, Glostrup, Denmark) was used for 30 minutes at room temperature ...
-
bioRxiv - Cancer Biology 2023Quote: ... The sections underwent peroxidase blocking (S2023, Agilent) for 5 minutes and washed with flex buffer ...
-
bioRxiv - Immunology 2024Quote: ... blocked in serum-free blocking reagent (Dako) ON at 4°C ...
-
bioRxiv - Immunology 2020Quote: ... consistently identified GFAP peptides while minimizing nonspecific off-target peptide identification (Agilent Z033429-2, 1:200 dilution). Each peptide was required to have a minimum of 1 RPK as well as a FC > 10 ...
-
bioRxiv - Cancer Biology 2021Quote: ... Labelled radioactive peptide was separated from unlabeled peptide by HPLC purification (Agilent ZORBAX 300 Extend-C18 column) using a gradient from 20-50% acetonitrile (+0.1 % TFA ...
-
bioRxiv - Immunology 2023Quote: ... VP peptides were injected onto an Advanced Peptide column (2.1 x 150 mm, 2.7 µm, Agilent Technologies), and separated using a LC gradient of 2-45% B (A ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... Labelled radioactive peptide was separated from unlabeled peptide by HPLC purification (Agilent ZORBAX 300 Extend-C18 column) using a gradient from 20-50% acetonitrile (+0.1 % TFA ...
-
bioRxiv - Plant Biology 2023Quote: ... Digested peptides were analysed with an AdvanceBio Peptide Map column (2.1×100 mm, 2.7 μm, Agilent Technologies, Inc.) and Infinity II 1290 UHPLC coupled to a 6550 iFunnel QTof (Agilent Technologies ...
-
bioRxiv - Genomics 2019Quote: ... Blocking was performed by 1h incubation in humid chamber with 3% of normal donkey serum (Vendor) in blocking solution (DAKO). Slides were incubated in humid chamber with primary antibodies overnight at 4°C and washed in PBS 0.2% Triton-X100 ...
-
bioRxiv - Pathology 2020Quote: ... Sections were allowed to thaw at RT and thereafter blocked for > 60 min at RT with blocking-buffer (serum-free protein blocking solution, DAKO), supplemented with 0.2% Triton X-100 (Sigma Aldrich) ...
-
bioRxiv - Cell Biology 2020Quote: ... Peptides were then desalted using OMIX (Agilent) and analyzed online by nano-flow HPLC-nanoelectrospray ionization using a Qexactive HF mass spectrometer (Thermo Fisher Scientific ...
-
bioRxiv - Cell Biology 2020Quote: ... Blocking was performed using 10% goat serum (Dako) in PBSTX for 1 h at RT or at 4°C overnight ...
-
bioRxiv - Cancer Biology 2019Quote: ... Blocking was done in Envision Peroxidase Blocker (Dako) for 15 minutes followed by incubation with 1:100 diluted IQGAP2 primary antibody (Abcam) ...
-
bioRxiv - Pathology 2020Quote: ... followed by peroxidase-blocking (Dako Cytomation A/S) on the sections and then heated at 100 °C for 60 min ...
-
bioRxiv - Synthetic Biology 2019Quote: ... After blocking with serum-free protein block (Dako), they were incubated with the primary antibodies for 120 min at room temperature ...
-
bioRxiv - Cancer Biology 2021Quote: ... Protein blocking was performed for 20 min (Dako). NUP210 primary antibody (Atlas ...
-
bioRxiv - Neuroscience 2022Quote: ... After blocking in normal serum (DAKO, Cambridgeshire, UK) primary antibody was applied overnight at 4 °C ...
-
bioRxiv - Cancer Biology 2022Quote: ... The sections then underwent peroxidase blocking (S2023, Agilent) for 5 minutes ...
-
bioRxiv - Cancer Biology 2019Quote: ... Slides were immersed with blocking solution (Agilent Technologies) for 15 min and subsequently replaced with anti-249T-P pAbs diluted at 1:250 with antibody diluent solution (Agilent Technologies) ...